China vs Lebanon: Previously treated cases tested for RR-/MDR-TB
China
92.0%
in 2024
Lebanon
92.0%
in 2024
China rank
79th
Lebanon rank
79th
Previously treated cases tested for RR-/MDR-TB over time
- China
- Lebanon
How they compare
China currently reports 92.0% against 92.0% in Lebanon, a difference of 0.0%.
The two have swapped places 2 times across 15 shared years of data; in 2006 it was Lebanon ahead.
China ranks 79th and Lebanon ranks 79th of 180 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.2% | 100.0% | 99.8% | Lebanon |
| 2010s | 62.0% | 83.0% | 21.0% | Lebanon |
| 2020s | 92.2% | 98.4% | 6.2% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, China or Lebanon?
- China, at 92.0% against 92.0% in Lebanon as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between China and Lebanon?
- 0.0%, with China ahead.
- How many years of comparable data are there for China and Lebanon?
- 15 years are reported by both, from 2006 to 2024.
- How do China and Lebanon rank globally for previously treated cases tested for rr-/mdr-tb?
- China ranks 79th and Lebanon ranks 79th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.